Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Icatibant acetate

EU orphan designation number: EU/3/03/133   
Active ingredient: Icatibant acetate
Indication: treatment of angioedema
Sponsor: Shire Orphan Therapies GmbH
Friedrichstraße 149, D-10117 Berlin, Deutschland
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Firazyr on 11/07/2008 with the number EU/1/08/461

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2003 Centralised Orphan - Designation EMEA/OD/054/02 (2003)615 of 17/02/2003
02/09/2013 Other procedure